American Society of Clinical Oncology, 45th Annual Meeting - Effect of octreotide (Sandostatin LAR) for neuroendocrine midgut tumors: The PROMID trial

P and T

Volumn 34, Issue 7, 2009, Pages 379-

  Alexander, Walter ^a   Arnold, Rudolf ^b   Yao, James C ^c  

^a Philipps University ^*

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; METASTASIS; MIDGUT; NEUROENDOCRINE TUMOR; TUMOR GROWTH;

EID: 68349118938     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)